RegeneRx Biopharmaceuticals Inc Sustainability Reports
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair, and regeneration. The company develops therapeutics centered around the novel therapeutic peptide Thymosin beta 4.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
2 reports from 2017 to 2019